The Pharmaceutical Journal
Vol 274 No 7338 p223
26 February 2005

This article
Reprint   Photocopy

  Acrobat Reader

News summary

Inquiry is opened into Shipman case pharmacist

The pharmacist criticised during the Shipman inquiry for not noticing the GP’s abnormal prescribing of diamorphine appeared before the Royal Pharmaceutical Society’s Statutory Committee this week.

The inquiry arose from a complaint by the Society’s Council alleging misconduct by Ghislaine Brant, who works in a pharmacy next door to the premises where Harold Shipman had his solo GP practice.

The inquiry attracted interest from the national news media. It was held on Monday and Tuesday and then adjourned to Thursday, after The Journal went to press.